Biousse Valérie, Tong Frank, Newman Nancy J.
Neuro-ophthalmology Unit, Emory Eye Center, 1365-B Clifton Road, Atlanta, GA 30322, USA.
Curr Treat Options Neurol. 2003 Sep;5(5):409-420. doi: 10.1007/s11940-003-0031-y.
Because of its wide range of presentations, its highly variable mode of onset, its numerous causes, and its unpredictable outcome, cerebral venous thrombosis (CVT) remains a diagnostic and therapeutic challenge. Treatment of CVT consists primarily of symptomatic treatment of seizures and intracranial hypertension, antithrombotics, and etiologic treatment whenever possible. Heparin remains the first line of treatment for CVT; although its systematic use remains debated, recent studies have confirmed its safety even in patients with large hemorrhagic infarctions. The addition of local thrombolysis is indicated for patients with clinical worsening related to extension of the venous thrombosis, despite adequate anticoagulation and optimal symptomatic and etiologic treatment. In contrast to arterial stroke, complete recovery of prolonged or severe neurologic deficit is possible, justifying initiation of anticoagulation and eventually thrombolysis, even when the clinical situation seems desperate. New techniques using mechanical devices disrupting the clot may be used in addition to thrombolysis in rare cases. Ventricular drainage is indicated in cases of cerebellar infarction or deep venous thrombosis associated with hydrocephalus. Decompressive craniotomy may be performed acutely in patients with untractable intracranial hypertension and herniation.
由于其临床表现多样、起病方式高度可变、病因众多且预后不可预测,脑静脉血栓形成(CVT)仍然是一个诊断和治疗难题。CVT的治疗主要包括对癫痫发作和颅内高压进行对症治疗、使用抗栓药物,并尽可能进行病因治疗。肝素仍然是CVT的一线治疗药物;尽管其系统性使用仍存在争议,但近期研究已证实其安全性,即使在患有大面积出血性梗死的患者中也是如此。对于尽管进行了充分抗凝以及最佳的对症和病因治疗,但仍因静脉血栓扩展而出现临床恶化的患者,需加用局部溶栓治疗。与动脉性卒中不同,即使临床情况看似绝望,长期或严重神经功能缺损仍有可能完全恢复,这使得即使在这种情况下也有理由启动抗凝治疗并最终进行溶栓治疗。在罕见情况下,除溶栓治疗外,还可使用采用机械装置破坏血栓的新技术。对于伴有脑积水的小脑梗死或深静脉血栓形成病例,需进行脑室引流。对于患有顽固性颅内高压和脑疝的患者,可紧急进行去骨瓣减压术。